シングルユースバイオプロセシング市場：製品、ワークフロー、用途、最終用途別-2025-2030年世界予測

シングルユースバイオプロセシング市場は、2023年に155億5,000万米ドルと評価され、2024年には175億6,000万米ドルに達すると予測され、CAGR 13.27％で成長し、2030年には372億2,000万米ドルになると予測されています。

シングルユースバイオプロセシングは、バイオテクノロジーにおける革命的な技術であり、主にバイオ医薬品の製造において、生産工程に使い捨てシステムを使用します。このアプローチは、バッグ、ミキサー、バイオリアクターなどの滅菌済みシングルユースコンポーネントの使用によって定義され、洗浄と滅菌の必要性を排除することで、交差汚染とターンアラウンドタイムを削減します。シングルユースバイオプロセシングの必要性は、費用対効果、柔軟性、拡張性の要求から生じ、特に初期段階の臨床試験や小規模生産に有利です。シングルユースバイオプロセシングの用途は、細胞培養、発酵、精製、製剤化など医薬品開発の様々な段階にわたっており、主に医薬品、生物製剤、受託製造機関（CMO）などの業界にサービスを提供しています。市場は、生物製剤の需要急増、バイオプロセス技術の急速な進歩、研究開発投資の増加といった要因によってプラスの影響を受けています。個別化医療へのシフトや、迅速で適応性の高い生産方法へのニーズが、市場の成長をさらに後押ししています。しかし、ディスポーザブルの環境への影響に対する懸念、標準化の問題、単一サプライヤーへの依存度の高さといった課題が、大きな制約となっています。潜在的なビジネスチャンスは、より持続可能で堅牢なシングルユース技術の開拓、新興国市場への進出、技術革新に焦点を当てた戦略的パートナーシップにあります。企業は、シングルユース部品のリサイクル性と廃棄戦略を改善するための研究開発に投資することで、これらを活用することができます。研究開発と技術革新に最適な分野としては、シームレスな拡張性を提供する統合型シングルユースシステムの開発や、遺伝子治療や細胞治療などの分野におけるシングルユースアプリケーションの拡大が挙げられます。シングルユースバイオプロセシング市場はダイナミックで急速に進化しており、より高い効率性と持続可能性への競争を特徴としており、成長する生物製剤市場のニーズを満たすために継続的な革新と適応が必要とされています。

市場力学：急速に進化するシングルユースバイオプロセシング市場の主要市場インサイトを公開

シングルユースバイオプロセシング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • シングルユースバイオプロセシングのための革新的かつ高機能材料の研究開発活動の活発化
  • 生物学的操作のために汚染のない環境を維持する必要性に対する意識の高まり
  • 受託研究機関の世界の普及
• 市場抑制要因
  • シングルユースバイオプロセシングソリューションの統合における複雑さ
• 市場機会
  • 研究センター拡大のための政府および民間資金の増加
  • 環境に優しく生分解性のシングルユースバイオプロセシングソリューションの開発
• 市場の課題
  • シングルユースバイオプロセシングソリューションの耐久性と完全性に関する懸念

ポーターの5つの力：シングルユースバイオプロセシング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、シングルユースバイオプロセシング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：シングルユースバイオプロセシング市場における外部からの影響の把握

外部マクロ環境要因は、シングルユースバイオプロセシング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析シングルユースバイオプロセシング市場における競合情勢の把握

シングルユースバイオプロセシング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスシングルユースバイオプロセシング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、シングルユースバイオプロセシング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨シングルユースバイオプロセシング市場における成功への道筋を描く

シングルユースバイオプロセシング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • シングルユースバイオプロセシングの革新的かつ高機能な材料の研究開発活動の強化
    • 生物学的操作において汚染のない環境を維持する必要性についての認識の高まり
    • 世界中で増加する委託調査機関
  • 抑制要因
    • シングルユースバイオプロセシングソリューションの統合における複雑さ
  • 機会
    • 研究センターの拡張に対する政府と民間からの資金の増加
    • 環境に優しく生分解性のあるシングルユースバイオプロセシングソリューションの開発
  • 課題
    • シングルユースバイオプロセシングソリューションの耐久性と整合性に関する懸念
• 市場セグメンテーション分析
  • 製品：細胞培養における使い捨てバイオリアクターの中心的な役割
  • エンドユーザー：製薬会社およびバイオテクノロジー会社が幅広い要件をサポートするためにシングルユースバイオプロセシングソリューションを採用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 シングルユースバイオプロセシング市場：製品別

• バイオプロセスドラムライナーとアクセサリー
• 使い捨てミキサー
• 使い捨てバイオリアクター
• 濾過アセンブリ
• 流体移送アセンブリ
• メディアバッグとコンテナ
• チューブ、コネクタ、サンプラー

第7章 シングルユースバイオプロセシング市場：ワークフロー別

• 下流
• 発酵
• 上流

第8章 シングルユースバイオプロセシング市場：用途別

• 無菌充填
• 細胞培養
• 濾過
• 混合
• 精製
• サンプリング
• ストレージ

第9章 シングルユースバイオプロセシング市場：エンドユーザー別

• 学術調査機関
• 契約製造組織
• 契約調査機関
• 製薬・バイオテクノロジー企業

第10章 南北アメリカのシングルユースバイオプロセシング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のシングルユースバイオプロセシング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのシングルユースバイオプロセシング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ミリポアシグマの使い捨てリアクターが効率70%向上を達成
  • フロイデンベルグのシングルユースバイオプロセシングアセンブリへの戦略的拡張により、漏れのない流体経路と運用効率の向上が保証されます。
  • Novo Holdings、Single Use Supportの過半数株式を取得してバイオプロセスサプライチェーンを強化
  • SaniSureの新しいFill4Sureアセンブリは、医薬品製造の合理化、コスト削減、生産効率の向上を目指しています。
  • ゲティンゲ、ドラッグデリバリーを加速し、バイオプロセスの効率を高める使い捨て生産リアクターシステムを導入
  • メルク、バイオプロセス用途向けに画期的な耐久性と効率性を備えた使い捨てフィルム「Ultimus」を発表
• 戦略分析と提言
  • サーモフィッシャーサイエンティフィックの戦略的成長機会の探究シングルユースバイオプロセシング市場

企業一覧

• Applikon Biotechnology BV by Getinge AB
• Aseptic Group by EnPro Industries
• Avantor, Inc.
• BioPharma Dynamics Ltd.
• BioSpectrum India
• Boyd Biomedical, Inc.
• Corning Incorporated
• Danaher Corporation
• Entegris, Inc.
• Eppendorf AG
• Foxx Life Sciences
• GE Healthcare
• Kuhner AG
• Liquidyne Process Technologies, Inc
• Lonza Group AG
• Meissner Filtration Products, Inc.
• Merck KGaA
• Parker Hannifin Corporation
• PBS Biotech, Inc.
• Repligen Corporation
• Saint-Gobain Performance Plastics, Inc.
• Sartorius AG
• Single Use Support GmbH
• Thermo Fisher Scientific Inc.
• Watson-Marlow Fluid Technology Solutions

LIST OF FIGURES

• FIGURE 1. SINGLE-USE BIOPROCESSING MARKET RESEARCH PROCESS
• FIGURE 2. SINGLE-USE BIOPROCESSING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. SINGLE-USE BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. SINGLE-USE BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SINGLE-USE BIOPROCESSING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SINGLE-USE BIOPROCESSING MARKET DYNAMICS
• TABLE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS DRUMS LINERS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DISPOSABLE MIXERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DISPOSABLE OR SINGLE-USE BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION ASSEMBLIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FLUID TRANSFER ASSEMBLIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MEDIA BAGS & CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, CONNECTORS, & SAMPLERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 47. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CANADA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 69. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. INDIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. INDIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 73. INDIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. MALAYSIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 85. MALAYSIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. MALAYSIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. PHILIPPINES SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 89. PHILIPPINES SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. PHILIPPINES SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SINGAPORE SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 93. SINGAPORE SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SINGAPORE SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH KOREA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 97. SOUTH KOREA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. SOUTH KOREA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. TAIWAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 101. TAIWAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. TAIWAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. THAILAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 105. THAILAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. THAILAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. VIETNAM SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 109. VIETNAM SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. VIETNAM SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. DENMARK SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 118. DENMARK SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. DENMARK SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. EGYPT SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 122. EGYPT SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. EGYPT SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. FINLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 126. FINLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. FINLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. FRANCE SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 130. FRANCE SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. FRANCE SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 134. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. GERMANY SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. ISRAEL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 138. ISRAEL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. ISRAEL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. ITALY SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. ITALY SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 142. ITALY SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. ITALY SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. NETHERLANDS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 146. NETHERLANDS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NETHERLANDS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. NIGERIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 150. NIGERIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. NIGERIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. NORWAY SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 154. NORWAY SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. NORWAY SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. POLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. POLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 158. POLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. POLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. QATAR SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. QATAR SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 162. QATAR SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. QATAR SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. RUSSIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 166. RUSSIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. RUSSIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. SAUDI ARABIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 170. SAUDI ARABIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SAUDI ARABIA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. SPAIN SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 178. SPAIN SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SPAIN SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. SWEDEN SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 182. SWEDEN SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. SWEDEN SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. SWITZERLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 186. SWITZERLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. SWITZERLAND SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. TURKEY SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 190. TURKEY SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. TURKEY SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. UNITED ARAB EMIRATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 194. UNITED ARAB EMIRATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. UNITED ARAB EMIRATES SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 198. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. UNITED KINGDOM SINGLE-USE BIOPROCESSING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. SINGLE-USE BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 201. SINGLE-USE BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023

The Single-use Bioprocessing Market was valued at USD 15.55 billion in 2023, expected to reach USD 17.56 billion in 2024, and is projected to grow at a CAGR of 13.27%, to USD 37.22 billion by 2030.

Single-use bioprocessing, a revolutionary technology in biotechnology, involves using disposable systems for production processes, primarily in the manufacturing of biopharmaceuticals. This approach is defined by its use of pre-sterilized, single-use components such as bags, mixers, and bioreactors, which eliminate the need for cleaning and sterilization, thus reducing cross-contamination and turnaround time. The necessity for single-use bioprocessing arises from its demand for cost-effectiveness, flexibility, and scalability, particularly advantageous in the early-stage clinical trials and small-scale production. Its applications stretch across various stages of drug development, including cell culture, fermentation, purification, and formulation, primarily serving industries such as pharmaceuticals, biologics, and contract manufacturing organizations (CMOs). The market is influenced positively by factors such as the skyrocketing demand for biologics, rapid advancements in bioprocessing technologies, and increased investment in research and development. The shift towards personalized medicine and the need for quick, adaptable production methods further propel its growth. However, challenges like concerns over the environmental impact of disposables, standardization issues, and high dependency on a single supplier base pose significant limitations. Potential opportunities lie in the development of more sustainable and robust single-use technologies, expansion into emerging markets, and strategic partnerships that focus on technological innovations. Companies can capitalize on these by investing in R&D to improve the recyclability and disposal strategies of single-use components. The best areas for research and innovation include developing integrated single-use systems that offer seamless scalability and expanding single-use applications in areas such as gene and cell therapies. The single-use bioprocessing market is dynamic and rapidly evolving, characterized by a race towards greater efficiency and sustainability, necessitating continuous innovation and adaptation to meet the needs of a growing biologics market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Single-use Bioprocessing Market

The Single-use Bioprocessing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increased research and development activities for innovative and highly functional materials for single-use bioprocessing
  • Growing awareness about the need to maintain contamination-free environments for biological operations
  • Proliferation of contract research organizations across the world
• Market Restraints
  • Complexities in the integration of single-use bioprocessing solutions
• Market Opportunities
  • Rising government and private funding for the expansion of research centers
  • Development of eco-friendly and biodegradable single-use bioprocessing solutions
• Market Challenges
  • Concerns related to the durability and integrity of single-use bioprocessing solutions

Porter's Five Forces: A Strategic Tool for Navigating the Single-use Bioprocessing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Single-use Bioprocessing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Single-use Bioprocessing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Single-use Bioprocessing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Single-use Bioprocessing Market

A detailed market share analysis in the Single-use Bioprocessing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Single-use Bioprocessing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Single-use Bioprocessing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Single-use Bioprocessing Market

A strategic analysis of the Single-use Bioprocessing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Single-use Bioprocessing Market, highlighting leading vendors and their innovative profiles. These include Applikon Biotechnology BV by Getinge AB, Aseptic Group by EnPro Industries, Avantor, Inc., BioPharma Dynamics Ltd., BioSpectrum India, Boyd Biomedical, Inc., Corning Incorporated, Danaher Corporation, Entegris, Inc., Eppendorf AG, Foxx Life Sciences, GE Healthcare, Kuhner AG, Liquidyne Process Technologies, Inc, Lonza Group AG, Meissner Filtration Products, Inc., Merck KGaA, Parker Hannifin Corporation, PBS Biotech, Inc., Repligen Corporation, Saint-Gobain Performance Plastics, Inc., Sartorius AG, Single Use Support GmbH, Thermo Fisher Scientific Inc., and Watson-Marlow Fluid Technology Solutions.

Market Segmentation & Coverage

This research report categorizes the Single-use Bioprocessing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Bioprocess Drums Liners & Accessories, Disposable Mixers, Disposable or Single-Use Bioreactors, Filtration Assemblies, Fluid Transfer Assemblies, Media Bags & Containers, and Tubing, Connectors, & Samplers.
• Based on Workflow, market is studied across Downstream, Fermentation, and Upstream.
• Based on Application, market is studied across Aseptic Filling, Cell Culture, Filtration, Mixing, Purification, Sampling, and Storage.
• Based on End-User, market is studied across Academic & Research Institutes, Contract Manufacturing Organizations, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased research and development activities for innovative and highly functional materials for single-use bioprocessing
    • 5.1.1.2. Growing awareness about the need to maintain contamination-free environments for biological operations
    • 5.1.1.3. Proliferation of contract research organizations across the world
  • 5.1.2. Restraints
    • 5.1.2.1. Complexities in the integration of single-use bioprocessing solutions
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising government and private funding for the expansion of research centers
    • 5.1.3.2. Development of eco-friendly and biodegradable single-use bioprocessing solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns related to the durability and integrity of single-use bioprocessing solutions
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Central role played by single-use bioreactors in the cultivation of cells
  • 5.2.2. End-User: Adoption of single-use bioprocessing solutions by the pharmaceutical & biotechnology companies to support their extensive requirements
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Single-use Bioprocessing Market, by Product

• 6.1. Introduction
• 6.2. Bioprocess Drums Liners & Accessories
• 6.3. Disposable Mixers
• 6.4. Disposable or Single-Use Bioreactors
• 6.5. Filtration Assemblies
• 6.6. Fluid Transfer Assemblies
• 6.7. Media Bags & Containers
• 6.8. Tubing, Connectors, & Samplers

7. Single-use Bioprocessing Market, by Workflow

• 7.1. Introduction
• 7.2. Downstream
• 7.3. Fermentation
• 7.4. Upstream

8. Single-use Bioprocessing Market, by Application

• 8.1. Introduction
• 8.2. Aseptic Filling
• 8.3. Cell Culture
• 8.4. Filtration
• 8.5. Mixing
• 8.6. Purification
• 8.7. Sampling
• 8.8. Storage

9. Single-use Bioprocessing Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Contract Manufacturing Organizations
• 9.4. Contract Research Organizations
• 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Single-use Bioprocessing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Single-use Bioprocessing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Single-use Bioprocessing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. MilliporeSigma's single-use reactor achieves 70% efficiency boost
  • 13.3.2. Freudenberg's strategic expansion into single-use bioprocessing assemblage ensures leak-free fluid pathways and operational efficiency enhancement
  • 13.3.3. Novo Holdings fortifies bioprocessing supply chain with majority stake in Single Use Support
  • 13.3.4. New Fill4Sure Assembly by SaniSure Aims to Streamline Drug Manufacturing, Cut Costs, and Enhance Production Efficiency
  • 13.3.5. Getinge Introduces Single-Use Production Reactor System to Accelerate Drug Delivery and Enhance Bioprocessing Efficiency
  • 13.3.6. Merck Unveils Ultimus Single-Use Film with Breakthrough Durability and Efficiency for Bioprocessing Applications
• 13.4. Strategy Analysis & Recommendation
  • 13.4.1. Exploring strategic growth opportunities for Thermo Fisher Scientific in the single-use bioprocessing market

Companies Mentioned

• 1. Applikon Biotechnology BV by Getinge AB
• 2. Aseptic Group by EnPro Industries
• 3. Avantor, Inc.
• 4. BioPharma Dynamics Ltd.
• 5. BioSpectrum India
• 6. Boyd Biomedical, Inc.
• 7. Corning Incorporated
• 8. Danaher Corporation
• 9. Entegris, Inc.
• 10. Eppendorf AG
• 11. Foxx Life Sciences
• 12. GE Healthcare
• 13. Kuhner AG
• 14. Liquidyne Process Technologies, Inc
• 15. Lonza Group AG
• 16. Meissner Filtration Products, Inc.
• 17. Merck KGaA
• 18. Parker Hannifin Corporation
• 19. PBS Biotech, Inc.
• 20. Repligen Corporation
• 21. Saint-Gobain Performance Plastics, Inc.
• 22. Sartorius AG
• 23. Single Use Support GmbH
• 24. Thermo Fisher Scientific Inc.
• 25. Watson-Marlow Fluid Technology Solutions